Search

everythinglearnresearchcommunity

for

Search:↓

Prostaglandin E2 helps prevent hair loss from radiotherapy by protecting hair growth cells and aiding self-repair.

Minoxidil stops cells from making prostacyclin, which may help with hair growth. More research is needed.

Finasteride weakens the bone-protective effects of certain blockers in low androgen conditions.

A new compound may treat benign prostatic hyperplasia better than finasteride.

MK-0773 is a moderate inhibitor of the SRD5A2 enzyme.

Eribulin-based chemotherapy is more effective and has fewer side effects for advanced triple-negative breast cancer.

Targeting the PIEZO1 and MLCK axis may offer a new treatment for hair loss.

Finasteride and dutasteride reduce unwanted movements from Parkinson's disease treatment by normalizing certain brain signals.

Bilateral Orchiectomy effectively reduces the need for anti-androgen medication in most transgender females.

New molecules can prevent cell death in hair follicles.

A new anti-baldness patch effectively treats hair loss by blocking enzymes linked to the condition.

LGD1069 effectively prevents breast tumors in mice without toxicity.

Certain immune cells in the skin can stop hair from growing.

LX-38 is a safer drug option for treating prostate issues and hair loss without hormonal side effects.

Forsythiaside A helps protect cells and liver from damage by reducing oxidative stress and boosting antioxidants.

Necrostatin-1s can promote hair growth and may help treat hair loss.

LX-38 is a safer drug option for hair loss and prostate issues without hormonal side effects.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

Neurosteroids help control dopamine responses in the brain.

Future osteoporosis treatments should focus on increasing bone growth, with many promising options available.

A new compound from a sponge strongly inhibits an enzyme linked to male-pattern hair loss without being toxic at low levels.

Targeting SIRT1 with antisense oligonucleotides could be a promising treatment for hair loss.

The document concludes that careful diagnosis is crucial for chromosome 13q deletion syndrome, tamoxifen can cause reversible eye damage, finasteride may be linked to cataracts, and OCT is useful for diagnosing macular diseases.

Hair loss in two ferrets was caused by ovarian tissue tumors, not adrenal issues.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Finasteride reduces hair loss by blocking testosterone's effects on scalp cells.